Therapeutic-area Dossier
Other
Therapeutic-area Dossier for Other (registered medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC outcomes — compiled by…
- Brand: APO-CLONIDINE
- Brand: Baxter
- Brand: DIAMOX
- Brand: Lanoxin-PG
- Brand: OXYTROL
- Brand: WAXSOL
- Sponsor: Fresenius Kabi
- Sponsor: Baxter Healthcare
- Sponsor: Seqirus
- Sponsor: Phebra
What is
Other The Other therapeutic area encompasses a diverse range of products, with 145 brands currently registered. This area includes products such as Baxter, ELUCIREM, GLYCOPHOS, DEXAMETHASONE VIATRIS, ADDAVEN, TISSEEL, SMOFKABIVEN, ACETADOTE, AMERSHAM, AMINOVEN, BIOLOGICAL, and BROWN among its registered brands.
Brands registered in
Other The top brands registered in this therapeutic area include: — Baxter — ELUCIREM — GLYCOPHOS — DEXAMETHASONE VIATRIS — ADDAVEN — TISSEEL — SMOFKABIVEN — ACETADOTE — AMERSHAM — AMINOVEN — BIOLOGICAL — BROWN
Sponsor landscape
The Other therapeutic area has 69 active sponsors. The leading sponsors in this area are Fresenius Kabi, Seqirus, Baxter Healthcare, Colgate-Palmolive, PharmaCrop, Phebra, Onelife Labs, and Medcan Australia Pty Ltd ATF Medcan Australia Trust.
PBS and regulatory activity
One brand in this therapeutic area has PBS-listed items, with the latest PBS schedule dated 1 May 2026. The most recent PBAC outcome in this area is from 1 March 2018, with one brand recorded. The latest AusPAR was issued on 15 April 2025, with five brands having AusPARs on record.